Researchers identify early neuroinflammation in people with Down syndrome, providing insight into Alzheimer’s risk and paving the way for preventive therapies.

Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...